In another example, a recent meta-analysis investigated the efficacy and safety of prostate-specific antigen (PSA) testing to screen for prostate cancer and showed that it does not affect overall (all-cause) mortality [13]. This evidence concerns the gene KLK3 and Familial prostate cancer.